Editorial: Clostridioides difficile infection
- PMID: 38468753
- PMCID: PMC10925766
- DOI: 10.3389/fmed.2024.1372813
Editorial: Clostridioides difficile infection
Keywords: CDI underdiagnosis; COVID-19 pandemic; Clostridiodes difficile asymptomatic carriers; Clostridioides difficile infection; community CDI; companion animals and Clostridioides difficile; delayed CDI diagnosis; misdiagnosis.
Conflict of interest statement
NP reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from MSD, Pfizer, Novartis, BD, Johnson and Johnson, GlaxoSmithKline, Novartis, Tillots, Thermo Fisher Scientific, and Roche; support from European Society for Clinical Microbiology and Infectious Diseases (ESCMID) to attend European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); and is on the data safety monitoring board for ImmuneMed. GG reports payment or honoraria for lectures and presentations from MSD, Tillots. FB is advisory board member for and/or has received scientific grants from Abbott, Astellas, Biomérieux, Cepheid, Cubist, Da Volterra, Elitech, Danone, Hologic, Merck, Pfizer, Quidel, Sanofi Pasteur, Summit, and Tillots.
Comment on
- Editorial on the Research Topic Clostridioides difficile infection
References
-
- Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. . Healthcare-Associated Infections Prevalence Study Group. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. (2018) 23:1800516. 10.2807/1560-7917.ES.2018.23.46.1800516 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
